{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T04:41:11Z","timestamp":1791261671783,"version":"4.1.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:00:00Z","timestamp":1777507200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:00:00Z","timestamp":1777507200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["U19: AG063911"],"award-info":[{"award-number":["U19: AG063911"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["U01 AG045390"],"award-info":[{"award-number":["U01 AG045390"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["U19: AG063911"],"award-info":[{"award-number":["U19: AG063911"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["U54 NS092089"],"award-info":[{"award-number":["U54 NS092089"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["U01 AG045390"],"award-info":[{"award-number":["U01 AG045390"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["U54 NS092089"],"award-info":[{"award-number":["U54 NS092089"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1007\/s00415-026-13839-5","type":"journal-article","created":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T09:17:52Z","timestamp":1777540672000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Factors influencing accelerated progression in behavioral variant frontotemporal dementia"],"prefix":"10.1007","volume":"273","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2342-0150","authenticated-orcid":false,"given":"Molly","family":"Split","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachary J.","family":"Kunicki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daliah","family":"Ross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Keszycki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Prieto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masood","family":"Manoochehri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alyssa N.","family":"De Vito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Appleby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chadwick M.","family":"Hales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiadi","family":"Onyike","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corey T.","family":"McMillan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Irwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Knopman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas R.","family":"Galasko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dylan","family":"Wint","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik D.","family":"Roberson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel C.","family":"L\u00e9ger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ging-Yuek Robin","family":"Hsiung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilary W.","family":"Heuer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard J.","family":"Rosen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian M.","family":"Grant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian R.","family":"Mackenzie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Litvan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Kornak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin","family":"Kwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katya","family":"Rascovsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimiko","family":"Domoto-Reilly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Massimo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence S.","family":"Honig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leah K.","family":"Forsberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Carmela","family":"Tartaglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario F.","family":"Mendez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neill","family":"Graff-Radford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nupur","family":"Ghoshal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Ljubenkov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Ryan","family":"Darby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sami","family":"Barmada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Weintraub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzee","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Campbell","family":"Sullivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Boxer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam M.","family":"Staffaroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison","family":"Snyder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Bozoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Belen","family":"Pascual","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradford C.","family":"Dickerson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley F.","family":"Boeve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward D.","family":"Huey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Barker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,30]]},"reference":[{"key":"13839_CR1","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awr179","author":"K Rascovsky","year":"2011","unstructured":"Rascovsky K et al (2011) Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain. https:\/\/doi.org\/10.1093\/brain\/awr179","journal-title":"Brain"},{"key":"13839_CR2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awaa018","author":"S Ducharme","year":"2020","unstructured":"Ducharme S et al (2020) Recommendations to distinguish behavioural variant frontotemporal dementia from psychiatric disorders. Brain. https:\/\/doi.org\/10.1093\/brain\/awaa018","journal-title":"Brain"},{"key":"13839_CR3","doi-asserted-by":"publisher","DOI":"10.1111\/ene.70036","author":"J Flavell","year":"2025","unstructured":"Flavell J et al (2025) Factors associated with true\u2010positive and false\u2010positive diagnoses of behavioural variant frontotemporal dementia in 100 consecutive referrals from specialist physicians. Euro J Neurol. https:\/\/doi.org\/10.1111\/ene.70036","journal-title":"Euro J Neurol"},{"key":"13839_CR4","doi-asserted-by":"crossref","unstructured":"Woolley JD, Khan BK, Murthy NK, Miller BL, Rankin KP (2011) The diagnostic challenge of psychiatric symptoms in neurodegenerative disease; rates of and risk factors for prior psychiatric diagnosis in patients with early neurodegenerative disease. J Clin Psychiatry 72(2) Art. no. 2","DOI":"10.4088\/JCP.10m06382oli"},{"key":"13839_CR5","doi-asserted-by":"publisher","DOI":"10.1177\/08919887221130267","author":"C Sejourne","year":"2023","unstructured":"Sejourne C et al (2023) Demographic and symptom correlates of initial idiopathic psychiatric diagnosis in frontotemporal dementia. J Geriatr Psychiatry Neurol. https:\/\/doi.org\/10.1177\/08919887221130267","journal-title":"J Geriatr Psychiatry Neurol"},{"key":"13839_CR6","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-210179","author":"JLP Fieldhouse","year":"2025","unstructured":"Fieldhouse JLP et al (2025) Clinical phenotypes of behavioral variant frontotemporal dementia by age at onset. J Alzheimers Dis. https:\/\/doi.org\/10.3233\/JAD-210179","journal-title":"J Alzheimers Dis"},{"key":"13839_CR7","doi-asserted-by":"publisher","DOI":"10.1159\/000443205","author":"K Kansal","year":"2016","unstructured":"Kansal K et al (2016) Survival in frontotemporal dementia phenotypes: a meta-analysis. Dement Geriatr Cogn Disord. https:\/\/doi.org\/10.1159\/000443205","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"3","key":"13839_CR8","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1093\/brain\/awab365","volume":"145","author":"MS Barker","year":"2022","unstructured":"Barker MS et al (2022) Proposed research criteria for prodromal behavioural variant frontotemporal dementia. Brain 145(3):1079\u20131097. https:\/\/doi.org\/10.1093\/brain\/awab365","journal-title":"Brain"},{"key":"13839_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2019.01.012","author":"AM Staffaroni","year":"2020","unstructured":"Staffaroni AM et al (2020) Assessment of executive function declines in presymptomatic and mildly symptomatic familial frontotemporal dementia: NIH-EXAMINER as a potential clinical trial endpoint. Alzheimers Dement. https:\/\/doi.org\/10.1016\/j.jalz.2019.01.012","journal-title":"Alzheimers Dement"},{"key":"13839_CR10","doi-asserted-by":"publisher","DOI":"10.1111\/ene.13887","author":"S Agarwal","year":"2019","unstructured":"Agarwal S et al (2019) Predictors of survival and progression in behavioural variant frontotemporal dementia. Eur J Neurol. https:\/\/doi.org\/10.1111\/ene.13887","journal-title":"Eur J Neurol"},{"issue":"1","key":"13839_CR11","doi-asserted-by":"publisher","DOI":"10.1002\/dad2.12262","volume":"13","author":"S Anderl-Straub","year":"2021","unstructured":"Anderl-Straub S et al (2021) Predicting disease progression in behavioral variant frontotemporal dementia. Alzheimers Dement Diagn Assess Dis Monit 13(1):e12262. https:\/\/doi.org\/10.1002\/dad2.12262","journal-title":"Alzheimers Dement Diagn Assess Dis Monit"},{"key":"13839_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2024.1382593","volume":"16","author":"JLP Fieldhouse","year":"2024","unstructured":"Fieldhouse JLP et al (2024) The pursuit for markers of disease progression in behavioral variant frontotemporal dementia: a scoping review to optimize outcome measures for clinical trials. Front Aging Neurosci 16:1382593. https:\/\/doi.org\/10.3389\/fnagi.2024.1382593","journal-title":"Front Aging Neurosci"},{"issue":"12","key":"13839_CR13","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1001\/jamaneurol.2015.2061","volume":"72","author":"E Devenney","year":"2015","unstructured":"Devenney E et al (2015) Progression in behavioral variant frontotemporal dementia: a longitudinal study. JAMA Neurol 72(12):1501\u20131509. https:\/\/doi.org\/10.1001\/jamaneurol.2015.2061","journal-title":"JAMA Neurol"},{"key":"13839_CR14","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000334299.72023.c8","author":"M Hornberger","year":"2008","unstructured":"Hornberger M, Piguet O, Kipps C, Hodges JR (2008) Executive function in progressive and nonprogressive behavioral variant frontotemporal dementia. Neurology. https:\/\/doi.org\/10.1212\/01.wnl.0000334299.72023.c8","journal-title":"Neurology"},{"key":"13839_CR15","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3181c1dee7","author":"B Garcin","year":"2009","unstructured":"Garcin B et al (2009) Determinants of survival in behavioral variant frontotemporal dementia. Neurology. https:\/\/doi.org\/10.1212\/WNL.0b013e3181c1dee7","journal-title":"Neurology"},{"issue":"Pt 2","key":"13839_CR16","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1093\/brain\/awq348","volume":"134","author":"KA Josephs","year":"2011","unstructured":"Josephs KA et al (2011) Predicting functional decline in behavioural variant frontotemporal dementia. Brain 134(Pt 2):432\u2013448. https:\/\/doi.org\/10.1093\/brain\/awq348","journal-title":"Brain"},{"issue":"11","key":"13839_CR17","doi-asserted-by":"publisher","first-page":"3158","DOI":"10.1111\/ene.15518","volume":"29","author":"Z Long","year":"2022","unstructured":"Long Z, Irish M, Hodges JR, Piguet O, Burrell JR (2022) Distinct disease trajectories in frontotemporal dementia-motor neuron disease and behavioural variant frontotemporal dementia: a longitudinal study. Eur J Neurol 29(11):3158\u20133169. https:\/\/doi.org\/10.1111\/ene.15518","journal-title":"Eur J Neurol"},{"key":"13839_CR18","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000007249","author":"CJ Lansdall","year":"2019","unstructured":"Lansdall CJ et al (2019) Prognostic importance of apathy in syndromes associated with frontotemporal lobar degeneration. Neurology. https:\/\/doi.org\/10.1212\/WNL.0000000000007249","journal-title":"Neurology"},{"issue":"7","key":"13839_CR19","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000209793","volume":"103","author":"B Borroni","year":"2024","unstructured":"Borroni B et al (2024) Predictors of care home admission and survival rate in patients with syndromes associated with frontotemporal lobar degeneration in Europe. Neurology 103(7):e209793. https:\/\/doi.org\/10.1212\/WNL.0000000000209793","journal-title":"Neurology"},{"key":"13839_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)00737-6","author":"JR Burrell","year":"2016","unstructured":"Burrell JR et al (2016) The frontotemporal dementia-motor neuron disease continuum. Lancet. https:\/\/doi.org\/10.1016\/S0140-6736(16)00737-6","journal-title":"Lancet"},{"issue":"22","key":"13839_CR21","doi-asserted-by":"publisher","first-page":"1886","DOI":"10.1212\/WNL.0b013e31821d767b","volume":"76","author":"EA Coon","year":"2011","unstructured":"Coon EA, Sorenson EJ, Whitwell JL, Knopman DS, Josephs KA (2011) Predicting survival in frontotemporal dementia with motor neuron disease. Neurology 76(22):1886\u20131892. https:\/\/doi.org\/10.1212\/WNL.0b013e31821d767b","journal-title":"Neurology"},{"issue":"10","key":"13839_CR22","doi-asserted-by":"publisher","first-page":"2194","DOI":"10.1038\/s41591-022-01942-9","volume":"28","author":"AM Staffaroni","year":"2022","unstructured":"Staffaroni AM et al (2022) Temporal order of clinical and biomarker changes in familial frontotemporal dementia. Nat Med 28(10):2194\u20132206","journal-title":"Nat Med"},{"key":"13839_CR23","doi-asserted-by":"publisher","DOI":"10.1002\/alz.12033","author":"T Miyagawa","year":"2020","unstructured":"Miyagawa T et al (2020) Utility of the global CDR\u00ae plus NACC FTLD rating and development of scoring rules: data from the ARTFL\/LEFFTDS Consortium. Alzheimers Dement. https:\/\/doi.org\/10.1002\/alz.12033","journal-title":"Alzheimers Dement"},{"key":"13839_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2019.06.4947","author":"B Boeve","year":"2020","unstructured":"Boeve B et al (2020) The longitudinal evaluation of familial frontotemporal dementia subjects protocol: framework and methodology. Alzheimers Dement. https:\/\/doi.org\/10.1016\/j.jalz.2019.06.4947","journal-title":"Alzheimers Dement"},{"issue":"6","key":"13839_CR25","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/BF00839964","volume":"240","author":"AM Chancellor","year":"1993","unstructured":"Chancellor AM, Slattery JM, Fraser H, Swingler RJ, Holloway SM, Warlow CP (1993) The prognosis of adult-onset motor neuron disease: a prospective study based on the Scottish Motor Neuron Disease Register. J Neurol 240(6):339\u2013346. https:\/\/doi.org\/10.1007\/BF00839964","journal-title":"J Neurol"},{"issue":"7","key":"13839_CR26","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1212\/WNL.0000000000002373","volume":"86","author":"KG Ranasinghe","year":"2016","unstructured":"Ranasinghe KG et al (2016) Cognition and neuropsychiatry in behavioral variant frontotemporal dementia by disease stage. Neurology 86(7):600\u2013610. https:\/\/doi.org\/10.1212\/WNL.0000000000002373","journal-title":"Neurology"},{"key":"13839_CR27","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awn234","author":"DS Knopman","year":"2008","unstructured":"Knopman DS et al (2008) Development of methodology for conducting clinical trials in frontotemporal lobar degeneration. Brain. https:\/\/doi.org\/10.1093\/brain\/awn234","journal-title":"Brain"},{"key":"13839_CR28","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/j.dadm.2019.08.003","volume":"11","author":"J Kornak","year":"2019","unstructured":"Kornak J et al (2019) Nonlinear Z-score modeling for improved detection of cognitive abnormality. Alzheimers Dement Diagn Assess Dis Monit 11:797\u2013808. https:\/\/doi.org\/10.1016\/j.dadm.2019.08.003","journal-title":"Alzheimers Dement Diagn Assess Dis Monit"},{"key":"13839_CR29","volume-title":"A compendium of neuropsychological tests: administration, norms, and commentary","author":"E Strauss","year":"2006","unstructured":"Strauss E, Sherman EM, Spreen O (2006) A compendium of neuropsychological tests: administration, norms, and commentary. Oxford University Press"},{"key":"13839_CR30","unstructured":"S. Fahn (1987) Unified Parkinson\u2019s disease rating scale. Recent developments in Parkinson\u2019s disease, pp 153\u2013163"},{"key":"13839_CR31","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000200860","author":"PW Tipton","year":"2022","unstructured":"Tipton PW et al (2022) Differences in motor features of C9orf72, MAPT, or GRN variant carriers with familial frontotemporal lobar degeneration. Neurology. https:\/\/doi.org\/10.1212\/WNL.0000000000200860","journal-title":"Neurology"},{"key":"13839_CR32","doi-asserted-by":"crossref","unstructured":"McFadden D (2021) Quantitative methods for analysing travel behaviour of individuals: some recent developments. In Behavioural travel modelling. Routledge, pp 279\u2013318. Accessed Oct 24 2025. [Online]. Available: https:\/\/www.taylorfrancis.com\/chapters\/edit\/10.4324\/9781003156055-18\/quantitative-methods-analysing-travel-behaviour-individuals-daniel-mcfadden","DOI":"10.4324\/9781003156055-18"},{"key":"13839_CR33","doi-asserted-by":"publisher","DOI":"10.1177\/25424823251324391","author":"C Sejourne","year":"2025","unstructured":"Sejourne C et al (2025) Neuropsychiatric and behavioral symptom clusters in frontotemporal dementia. J Alzheimers Dis Rep. https:\/\/doi.org\/10.1177\/25424823251324391","journal-title":"J Alzheimers Dis Rep"},{"key":"13839_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(14)70324-2","author":"JD Rohrer","year":"2015","unstructured":"Rohrer JD et al (2015) Presymptomatic cognitive and neuroanatomical changes in genetic frontotemporal dementia in the Genetic Frontotemporal dementia Initiative (GENFI) study: a cross-sectional analysis. Lancet Neurol. https:\/\/doi.org\/10.1016\/S1474-4422(14)70324-2","journal-title":"Lancet Neurol"},{"key":"13839_CR35","doi-asserted-by":"publisher","DOI":"10.1002\/dad2.12318","author":"A Kamalian","year":"2022","unstructured":"Kamalian A et al (2022) Convergent regional brain abnormalities in behavioral variant frontotemporal dementia: a neuroimaging meta\u2010analysis of 73 studies. Alzheimers Dement Amst. https:\/\/doi.org\/10.1002\/dad2.12318","journal-title":"Alzheimers Dement Amst"},{"issue":"3","key":"13839_CR36","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1007\/s11065-023-09613-3","volume":"34","author":"L Macchitella","year":"2024","unstructured":"Macchitella L et al (2024) Genuine memory deficits as assessed by the Free and Cued Selective Reminding Test (FCSRT) in the behavioural variant of frontotemporal dementia. A systematic review and meta-analysis study. Neuropsychol Rev 34(3):823\u2013837. https:\/\/doi.org\/10.1007\/s11065-023-09613-3","journal-title":"Neuropsychol Rev"},{"key":"13839_CR37","doi-asserted-by":"publisher","DOI":"10.1017\/S1355617718000115","author":"JM Poos","year":"2018","unstructured":"Poos JM, Jiskoot LC, Papma JM, van Swieten JC, van den Berg E (2018) Meta-analytic review of memory impairment in behavioral variant frontotemporal dementia. J Int Neuropsychol Soc. https:\/\/doi.org\/10.1017\/S1355617718000115","journal-title":"J Int Neuropsychol Soc"},{"issue":"3","key":"13839_CR38","doi-asserted-by":"publisher","first-page":"801","DOI":"10.3233\/jad-160175","volume":"53","author":"N Dermody","year":"2016","unstructured":"Dermody N, Wong S, Ahmed R, Piguet O, Hodges JR, Irish M (2016) Uncovering the neural bases of cognitive and affective empathy deficits in Alzheimer\u2019s disease and the behavioral-variant of frontotemporal dementia. JAD 53(3):801\u2013816. https:\/\/doi.org\/10.3233\/jad-160175","journal-title":"JAD"},{"key":"13839_CR39","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.cortex.2019.09.012","volume":"121","author":"E Mitchell","year":"2019","unstructured":"Mitchell E, Tavares TP, Palaniyappan L, Finger EC (2019) Hoarding and obsessive\u2013compulsive behaviours in frontotemporal dementia: clinical and neuroanatomic associations. Cortex 121:443\u2013453","journal-title":"Cortex"},{"issue":"9","key":"13839_CR40","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1093\/brain\/awh598","volume":"128","author":"A Kertesz","year":"2005","unstructured":"Kertesz A, McMonagle P, Blair M, Davidson W, Munoz DG (2005) The evolution and pathology of frontotemporal dementia. Brain 128(9):1996\u20132005","journal-title":"Brain"},{"key":"13839_CR41","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awaa097","author":"AG Murley","year":"2020","unstructured":"Murley AG et al (2020) Redefining the multidimensional clinical phenotypes of frontotemporal lobar degeneration syndromes. Brain. https:\/\/doi.org\/10.1093\/brain\/awaa097","journal-title":"Brain"},{"key":"13839_CR42","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.3250","author":"M Tahedl","year":"2023","unstructured":"Tahedl M et al (2023) The involvement of language\u2010associated networks, tracts, and cortical regions in frontotemporal dementia and amyotrophic lateral sclerosis: structural and functional alterations. Brain Behav. https:\/\/doi.org\/10.1002\/brb3.3250","journal-title":"Brain Behav"},{"issue":"3","key":"13839_CR43","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcab158","volume":"3","author":"M Bocchetta","year":"2021","unstructured":"Bocchetta M, Malpetti M, Todd EG, Rowe JB, Rohrer JD (2021) Looking beneath the surface: the importance of subcortical structures in frontotemporal dementia. Brain Commun 3(3):fcab158","journal-title":"Brain Commun"},{"key":"13839_CR44","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-017-1679-9","author":"EB Lee","year":"2017","unstructured":"Lee EB et al (2017) Expansion of the classification of FTLD-TDP: distinct pathology associated with rapidly progressive frontotemporal degeneration. Acta Neuropathol. https:\/\/doi.org\/10.1007\/s00401-017-1679-9","journal-title":"Acta Neuropathol"},{"key":"13839_CR45","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2021-326868","author":"G Peakman","year":"2022","unstructured":"Peakman G et al (2022) Comparison of clinical rating scales in genetic frontotemporal dementia within the GENFI cohort. J Neurol Neurosurg Psychiatry. https:\/\/doi.org\/10.1136\/jnnp-2021-326868","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"13839_CR46","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.92.15_supplement.P5.1-010","author":"B Boeve","year":"2019","unstructured":"Boeve B et al (2019) The multidomain impairment rating (MIR) scale: initial reliability data on a multidimensional scale for FTLD (P5.1-010). Neurology. https:\/\/doi.org\/10.1212\/WNL.92.15_supplement.P5.1-010","journal-title":"Neurology"},{"issue":"4","key":"13839_CR47","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1093\/biomet\/26.4.404","volume":"26","author":"CJ Clopper","year":"1934","unstructured":"Clopper CJ, Pearson ES (1934) The use of confidence or fiducial limits illustrated in the case of the binomial. Biometrika 26(4):404\u2013413","journal-title":"Biometrika"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-026-13839-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-026-13839-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-026-13839-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T10:44:29Z","timestamp":1779446669000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-026-13839-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,30]]},"references-count":47,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["13839"],"URL":"https:\/\/doi.org\/10.1007\/s00415-026-13839-5","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,30]]},"assertion":[{"value":"7 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"M. Split, Ph.D.: Nothing to disclose. Z.J. Kunicki, Ph.D.: Nothing to disclose. D. Ross, Ph.D.: Nothing to disclose. R. Keszycki, Ph.D.: Nothing to disclose. S. Prieto, Ph.D.: Nothing to disclose. M. Manoochehri, B.A.: Nothing to disclose. A.N. De Vito, PhD.: Nothing to disclose. B.S. Appleby, M.D.: Receives research support from the Centers for Disease Control and Prevention, the National Institutes of Health (NIH), Ionis, Alector and the CJD Foundation. He has provided consultation to Acadia, Ionis and Sangamo. C. Onyike, MBBS, MHS: Receives research funding from the NIH, Department of Defense, Association for Frontotemporal Degeneration, Lawton Health Research Institute, National Ataxia Foundation, Alector and Denali. He is also supported by the Robert and Nancy Hall Brain Research Fund, the Jane Tanger Black Fund for Young-Onset Dementias and a gift from Joseph Trovato. He is a consultant with Alector Inc., Eli Lilly and Company, Otsuka Pharmaceutical, Reata Pharmaceuticals, and Neuvivo. C.T. McMillan, Ph.D.: Receives funding from NIH and Penn Institute on Aging. D. Clark, M.D.: Nothing to disclose. D. Irwin, M.D.: Receives support from the NIH, Penn Institute on Aging, Alector, Passage Bio, Prevail and Denali. D. Knopman, M.D.: Serves on a Data Safety Monitoring Board for the Dominantly Inherited Alzheimer Network Treatment Unit study sponsored by Washington University St Louis, and for the SMART-HS clinical trial (Univ of Kentucky). He was an investigator in Alzheimer clinical trials sponsored by Biogen, Lilly Pharmaceuticals and the University of Southern California, both of which have ended, and is currently an investigator in a trial in frontotemporal degeneration with Alector. He has served as a consultant for Roche, AriBio, Linus Health, Biovie and Alzeca Biosciences but receives no personal compensation. He receives funding from the NIH. D.R. Galasko, M.D.: Paid consultant for Biogen, vTv Pharmaceuticals, Cognition Theraptutics, Fujirebio and\u00a0Amprion and received payment as a journal Editor from Springer. D. Wint, MD: Nothing to disclose. E.D. Roberson, MD., Ph.D.: Has received research support from the NIH, the Bluefield Project to Cure Frontotemporal Dementia, the Alzheimer's Association, the Alzheimer's Drug Discovery Foundation, the BrightFocus Foundation, and Alector; has served as a consultant for AGTC and on a data monitoring committee for Lilly; and owns intellectual property related to tau. G.C. L\u00e9ger, MD: Nothing to disclose. G-Y. Hsiung, M.D.: Has served as an investigator for clinical trials sponsored by AstraZeneca, Eli Lilly and Roche\/Genentech. He receives research support from the Canadian Institutes of Health Research and the Alzheimer Society of British Columbia. H.W. Heuer, Ph.D.: Nothing to disclose. H.J. Rosen, M.D.: Has received consulting fees from Eli Lilly, and receives research support from the NIH and the state of California. I.M. Grant, M.D.: Nothing to disclose. I.R. Mackenzie, M.D.: Receives research funding from the Canadian Institutes of Health Research, the Alzheimer\u2019s Association US, the NIH and the Weston Brain Institute. I. Litvan, M.D., MSc: Research is supported by the National Institutes of Health grants: U19AG063911; U01NS100610; 2P30AG062429, R01AG085029; U01NS112010; P30AG062429-06; R25NS108939 and 1R61 NS141119-01 the Michael J Fox Foundation, Parkinson\u2019s Foundation, Lewy Body Association, CurePSP, Roche, AbbVie, Lundbeck, EIP-Pharma, Alterity, Novartis, and UCB. She is a member of the Scientific Advisory Board for the Rossy PSP Program at the University of Toronto, Aprinoia and Amydis (gratis). She receives her salary from the University of California San Diego and as Chief Editor of\n                      Frontiers in Neurology\n                      . J. Kornak, Ph.D.: Has provided expert witness testimony for Teva Pharmaceuticals in Forest Laboratories Inc. et al. v. Teva Pharmaceuticals USA, Inc., case numbers 1:14-cv-00121 and 1:14-cv-00686 (D. Del. filed 31 January 2014 and 30 May 2014 regarding the drug Memantine) and for Apotex\/HEC\/Ezra in Novartis AG et al. v. Apotex Inc., case number 1:15-cv-975 (D. Del. filed 26 October 2015 regarding the drug Fingolimod). He gave testimony on behalf of Puma Biotechnology in Hsingching Hsu et al., vs. Puma Biotechnology, Inc., et al. 2018 regarding the drug Neratinib. He gave testimony as expert for the Defendants in Plaintiffs Amarin Pharma, Inc. and Amarin Pharmaceuticals Ireland Limited vs. Defendants West- Ward Pharmaceuticals Corp., West-Ward Pharmaceuticals International, Ltd., Dr. Reddy\u2019s Laboratories, Inc., Dr. Reddy\u2019s Laboratories, Ltd., and Teva Pharmaceuticals USA in 2019. In July 2024, he gave deposition testimony as expert on behalf of defendants in Bondurant, Converse, Gallardo, Judkins, Newsome, Rauas vs. Johnson & Johnson. In January 2025, I gave testimony in Norway at the Oslo District court as expert on behalf of defendants in Samsung Bioepis NL B.V. vs. Janssen Biotech Inc. He receives research support from the NIH. J, Kwan, M.D.: Nothing to disclose. K. Rascovsky, Ph.D.: Receives research support from the NIH. K. Domoto-Reilly, M.D., MMSc: Receives research support from the NIH. L. Massimo, Ph.D.: Receives research support from the NIH. L.S. Honig, M.D., Ph.D.: Research Funding from Acumen, Alector, Alnylam, Aprinoia, Biogen, BMS, Cognition, Cervomed\/EIP, Eisai, Ferrer, Transposon, UCB, Vaccinex. Consulting fees from Biogen, Eisai, Medscape, New Amsterdam, Prevail\/Lilly, Genentech\/Roche, Vigil. L.K. Forsberg, Ph.D.: Receives research support from the NIH. M.C. Tartaglia, M.D.: Has served as an investigator for clinical trials sponsored by Biogen, Avanex, Green Valley, Roche\/Genentech, Bristol Myers Squibb, Eli Lilly\/Avid Radiopharmaceuticals, UCB, Novo Nordisk and Janssen. She receives research support from the Canadian Institutes of Health Research, National Institute of Aging, Tanenbaum Institute of Science in Sport, Weston Brain Foundation. She has consulted for Eisai, Lilly and Novo Nordisk. M.F. Mendez, M.D., Ph.D.: Receives research support from the NIH. N.R. Graff-Radford, MBBCh: Receives royalties from UpToDate and has participated in multicenter therapy studies by sponsored by Biogen, Lilly, Eisai and Cognition Therapeutics. He receives research support from the NIH. N. Ghoshal, M.D., Ph.D.: Has participated or is currently participating in clinical trials of anti-dementia drugs sponsored by Bristol Myers Squibb, Eli Lilly\/Avid Radiopharmaceuticals, Janssen Immunotherapy, Novartis, Pfizer, Wyeth, SNIFF (The Study of Nasal Insulin to Fight Forgetfulness) and the A4 (The Anti-Amyloid Treatment in Asymptomatic Alzheimer\u2019s Disease) trial. She receives research support from Tau Consortium and the Association for Frontotemporal Dementia and is funded by the NIH. She consults for BCBSA. P. Ljubenkov, M.D.: Has served as a site primary investigator for clinical trials sponsored by Alector, AbbVie, BMS, Transposon and Woolsey. His he receives research support from Biohaven. He receives research and salary support from the NIH-NIA and the Alzheimer\u2019s Association-Part the Cloud partnership. R.R. Darby, M.D.: Nothing to disclose. S. Barmada, M.D., Ph.D.: Nothing to disclose. S. Weintraub, Ph.D.: Receives research support from the NIH. S. Lee, M.D.: Nothing to disclose. A.C. Sullivan, PsyD: Nothing to disclose. A. Boxer, M.D., Ph.D.: Receives research support from the NIH, the Tau Research Consortium, the Association for Frontotemporal Degeneration, Bluefield Project to Cure Frontotemporal Dementia, Corticobasal Degeneration Solutions, the Alzheimer\u2019s Drug Discovery Foundation and the Alzheimer\u2019s Association. He has served as a consultant for Aeovian, AGTC, Alector, Arkuda, Arvinas, Boehringer Ingelheim, Denali, GSK, Life Edit, Humana, Oligomerix, Oscotec, Roche, TrueBinding, Wave, Merck and received research support from Biogen, Eisai and Regeneron. A.M. Staffaroni, Ph.D.: A.M.S. received research support from the NIA\/NIH, the Bluefield Project to Cure FTD, and the Association for Frontotemporal Degeneration. He has provided consultation to Alector, Aviado Bio, Cervomed, Prevail Therapeutics\/Eli Lilly, Passage Bio, Takeda, and Vesper Bio. A. Snyder, M.D.: Nothing to disclose. A. Bozoki, M.D.: Site PI: Novartis, EIP Pharma, Cognition Therapeutics, Alector. Therapeutics and Transposon Pharma. Project funding: Petauri Kinect. Advisory Board: Creative Biopeptides and Cognition Therapeutics. DSMB: AviadoBio. B. Pascual, Ph.D.: Nothing to disclose. B. C. Dickerson, M.D.: Works as a consultant for Acadia, Alector, Arkuda, Biogen, Cervomed, Eisai, Ilios, Lantheus, Lilly, Merck, Novo Nordisk, Quanterix; receives royalties from Cambridge University Press, Elsevier, Oxford University Press, and Up To Date; and receives grant funding from the NIA, the National Institute of Neurological Disorders and Stroke, the National Institute of Mental Health and the Bluefield Foundation. B. F. Boeve, M.D.: Has served as an investigator for clinical trials sponsored by Alector, EIP Pharma\/Cervomed, Biogen, Transposon and Cognition Therapeutics. He serves on the Scientific Advisory Board of the Tau Consortium which is funded by the Rainwater Charitable Foundation. He receives research support from NIH. E.D. Huey, M.D.: Receives research support from the NIH. M.S. Barker, Ph.D.: Nothing to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"All participants and\/or their legally authorized representatives provided written informed consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"This study has been conducted according to the principles of the Declaration of Helsinki and was approved by the Johns Hopkins School of Medicine Institutional Review Board and the Institutional Review Board of participating sites.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"297"}}